LifePoint Reports on THC and PCP Detection in Saliva At Society of
Forensic Toxicologists
- LifePoint(TM) Test System Shown to Provide a Rapid Screening Method for PCP And the Physiologically Active Component
of Marijuana -
ONTARIO, Calif., Oct. 3 /PRNewswire/ -- LifePoint, Inc. (Amex: LFP - news) today announced the presentation of results demonstrating the company's ability to detect PCP and
THC (marijuana) in human saliva with the LifePoint(TM) Test System at the annual meeting of The Society of Forensic Toxicologists in Milwaukee, WS.
The results were presented in two separate technical papers by Thomas Foley, Ph.D., LifePoint's senior vice-president of research & development. The first paper, titled,
``Detection of THC in Human Saliva by GC/MS and a Displacement Flow Immunoassay'' and the second paper, titled, ``A Rapid Instrumented Fluoresence Immunoassay for the
Detection of Phencyclidine (PCP) in Oral Fluids'' are both based on research conducted by Dr. Foley and co-workers at LifePoint.
``The use of saliva as a diagnostic tool is gaining significant interest for the detection of drugs of abuse as an alternative to blood and urine testing,'' stated Dr. Foley. ``The results
of our research show that the applications for the LifePoint(TM) Test System, an automated flow immunoassay, can be extended into the detection of PCP and THC, which are
found at very low levels in saliva, and therefore, cannot be easily performed except with very expensive and specialized lab equipment. The LifePoint(TM) Test System can be used
to simultaneously detect alcohol and the NIDA-5 Drugs (THC, PCP, opiates, cocaine, amphetamines/methamphetamines),'' he added.
The Society of Forensic Toxicologists holds an annual meeting of the thought leaders and influencers in the field of analytical toxicology. This year's meeting will highlight the
launching of 30 years of forensic toxicology into the next millennium. Over 500 leading toxicologists from North America will focus on detecting drugs in alternative specimens
(including saliva), evaluating drug concentration versus performance impairment, exploring workplace toxicology, and discussing analytical methods for drugs of abuse, among
other topics.
``We are pleased that LifePoint has been invited to present some of the recent technical data on saliva that we have generated during our product development program,'' said Linda
H. Masterson, President and CEO. ``Part of our strategy is to continue to make technical presentations about the validity and accuracy of our technologies and the LifePoint(TM)
Test System, which will provide the unique capability to provide immediate, quantitative, ''under-the-influence`` simultaneous results for drugs of abuse and alcohol.''
LifePoint, Inc. is a late development stage company designing the LifePoint(TM) Test System -- a rapid diagnostic testing, screening, and therapeutic drug monitoring device for
use in the workplace, home health care, ambulances, pharmacies and law enforcement. LifePoint is focused on the commercialization of the flow immunosensor technology
licensed from the Naval Research Laboratories. This patented technology, when used in conjunction with LifePoint's own patented and proprietary technologies on using saliva as
a non-invasive test specimen, will allow for the development of a broadly applicable non-invasive, rapid, on-site diagnostic test system. |
